These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2570653

  • 21. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
    Schleusener H, Schernthaner G, Mayr WR, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen K, Wenzel KW.
    J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
    [Abstract] [Full Text] [Related]

  • 22. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D, Massart C.
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [Abstract] [Full Text] [Related]

  • 23. Comparison of thyroid stimulating activities measured by cyclic AMP production, those by radioiodine uptake in FRTL-5 cells and TSH-binding inhibitory activities in patients with hyperthyroid and euthyroid Graves' diseases.
    Kasagi K, Hatabu H, Tokuda Y, Arai K, Iida Y, Konishi J.
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):365-72. PubMed ID: 2898192
    [Abstract] [Full Text] [Related]

  • 24. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K, Hidaka A, Nakamura H, Takeuchi R, Misaki T, Iida Y, Konishi J.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [Abstract] [Full Text] [Related]

  • 25. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies.
    McKenzie JM, Zakarija M.
    Thyroid; 1992 Feb; 2(2):155-9. PubMed ID: 1356056
    [Abstract] [Full Text] [Related]

  • 26. Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy.
    Jaume JC, Prummel MF, Wiersinga WM, McLachlan SM, Rapoport B.
    Thyroid; 1993 Feb; 3(4):291-5. PubMed ID: 7509670
    [Abstract] [Full Text] [Related]

  • 27. Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.
    Hörmann R, Saller B, Müller R, Mann K.
    Klin Wochenschr; 1985 Dec 16; 63(24):1247-52. PubMed ID: 2868149
    [Abstract] [Full Text] [Related]

  • 28. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
    Strakosch CR, Joyner D, Manley SW, Wall JR.
    Clin Endocrinol (Oxf); 1982 Aug 16; 17(2):173-9. PubMed ID: 6127179
    [Abstract] [Full Text] [Related]

  • 29. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J, Hosoya T, Naito N, Yoshimura H, Kohno Y, Tarutani O, Kuma K, Sakane S, Takeda K, Mozai T.
    J Clin Endocrinol Metab; 1988 Jan 16; 66(1):147-52. PubMed ID: 3335601
    [Abstract] [Full Text] [Related]

  • 30. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS, Sirbu AE, Betivoiu MA, Florea S, Barbu CG, Fica SV.
    Endocrine; 2017 Feb 16; 55(2):478-484. PubMed ID: 27819113
    [Abstract] [Full Text] [Related]

  • 31. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin.
    Mukuta T, Tamai H, Oshima A, Morita T, Matsubayashi S, Fukata S, Kuma K.
    Clin Endocrinol (Oxf); 1994 Feb 16; 40(2):215-9. PubMed ID: 7907955
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H, Amino N, Iwatani Y, Tachi J, Kimura M, Mitsuda N, Ichihara K, Tanizawa O, Miyai K.
    Clin Endocrinol (Oxf); 1989 May 16; 30(5):493-503. PubMed ID: 2575017
    [Abstract] [Full Text] [Related]

  • 33. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct 16; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 34. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF.
    Clin Endocrinol (Oxf); 2000 Mar 16; 52(3):267-71. PubMed ID: 10718823
    [Abstract] [Full Text] [Related]

  • 35. [Thyroid-stimulating immunoglobulins. The related antigens].
    Pinchera A, Fenzi GF, Macchia E, Vitti P, Monzani F, Kohn LD.
    Ann Endocrinol (Paris); 1982 Dec 16; 43(6):520-33. PubMed ID: 6134493
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.
    Macchia E, Fenzi GF, Monzani F, Bartalena L, Lippi F, Aloisio V, Cupini C, Baschieri L, Pinchera A.
    J Endocrinol Invest; 1983 Oct 16; 6(5):375-8. PubMed ID: 6141201
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy.
    Atkinson S, Holcombe M, Kendall-Taylor P.
    Lancet; 1984 Aug 18; 2(8399):374-6. PubMed ID: 6147455
    [Abstract] [Full Text] [Related]

  • 40. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
    Schmidt M, Gorbauch E, Dietlein M, Faust M, Stützer H, Eschner W, Theissen P, Schicha H.
    Thyroid; 2006 Mar 18; 16(3):281-8. PubMed ID: 16571091
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.